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Objectives: to evaluate the efficacy of infrainguinal bypass for limb-threatening ischaemia in patients with end-stage renal
disease (ESRD).
Materials and Methods: from 1991 through 2000, 28 limbs in 22 patients with ESRD received 33 infrainguinal bypasses,
while 65 limbs in 57 patients with functioning kidneys underwent 77 bypasses for limb salvage. The prevalence of diabetes
is higher in the ESRD group (p 0.03).
Results: perioperative mortality and patient survival rate in the follow-up period were significantly poorer in patients
with ESRD (18% vs 0%; p 0.001, and 45% vs 85%, p5 0.001, respectively). Most causes of death were related to
atherosclerosis or respiratory diseases. In spite of no significant difference in 2-year primary and secondary graft patency
rates and limb salvage between the ESRD and non-ESRD groups (76% vs 83%; p 0.12, 85% vs 91%; p 0.06, and 83%
vs 93%; p 0.06, respectively), two cases of early limb loss occurred as a result of uncontrolled infection in the ESRD
group. In contrast to autogenous conduits, nonautogenous conduits revealed a poorer outcome in ESRD patients
(p 0.03).
Conclusions: perioperative mortality and patient survival rate were significantly poorer in the ESRD group. Preoperative
full evaluation of myocardial and brain ischaemia, revascularisation with autogenous conduits, appropriate treatment of
wound infection, and strict follow-up for accompanying diseases may be needed in these patients.
Key Words: End-stage renal disease; Chronic renal failure; Critical limb ischaemia; Infrainguinal bypass; Autogenous
conduit; Uncontrolled infection.
Introduction
The population of patients with end-stage renal dis-
ease (ESRD) has been expanding in size and increas-
ing in age because of improvements in the treatment
of uremia and the availability of dialysis. The number
of patients receiving dialysis in Japan was more than
197 000, 0.15% of the Japanese population at the end of
1999. More than 10 000 patients start dialysis every
year, and diabetes mellitus accounts for 36% of new
cases in Japan.1 There is a high prevalence of peri-
pheral arterial occlusive disease in these patients,
which often results in limb-threatening ischaemia.
Although arterial reconstruction has been advocated
for these severely ischaemic limbs, the results are
discouraging because of higher morbidity and mortal-
ity and lower limb-salvaging rate, as compared with
patients with functioning kidneys.2±4 We have aggres-
sively performed arterial reconstruction, whenever
feasible, in patients with ESRD, because critical ischae-
mia without vascular reconstruction predicted a poor
outcome.5
In the present study, we documented the character-
istic features of infrainguinal arterial reconstruction in
patients with ESRD undergoing limb salvage opera-
tions compared with those of non-uremic controls.
Patients and Methods
Patients background
Medical records were reviewed for 79 consecutive
patients with limb-threatening ischaemia due to
arteriosclerosis obliterans (ASO) undergoing 110
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infrainguinal arterial reconstructive bypasses in 93
limbs from January 1991 through December 2000 at
the University of Tokyo Hospital, Saitama Medical
Center and Asahi General Hospital were reviewed.
These patients were divided into two groups, patiets
with and without ESRD. There were 22 patients with
ESRD with a mean age of 63 years, all dependent upon
haemodialysis for a mean period of 88 months.
Only one patient had a non-functioning transplanted
kidney. There were 57 patients with functioning
kidneys with a mean age of 68 years as controls.
Fifteen patients (68%) with ESRD had diabetes
mellitus, which is the leading cause of ESRD, and it is
more prevalent in the ESRD group (p 0.03). Critical
foot ischaemia was the indication for arterial recon-
struction. The demographic characteristics, associated
risk factors, and the indication for arterial bypass are
shown in Table 1. All patients underwent preoperative
angiography to evaluate the inflow and runoff vessels
in the affected limbs. `` Occlusive lesions'' were termed
as 100% occluded arteries at any length, and angio-
graphic findings were compared at aorto-iliac, fem-
oral, popliteal and tibial/peroneal (crural) levels
between ESRD and non-ESRD groups. The results of
angiography showed mutilevel involvement of occlu-
sive lesions in crural as well as femoral arteries in both
groups, and no difference was seen in the distribution
of lesions between these groups.
Cardiac ultrasound has been performed for pre-
operative cardiac function assessment in all patients
since 1993, and coronary angiography (CAG) was
done in patients with a history or a suspicion of
ischaemic heart disease due to abnormal electro-
cardiographic or ultrasound findings. Prior to arterial
reconstruction for lower limb ischaemia, one patient
was treated with percutaneous transluminal coronary
angioplasty and two with coronary artery bypass
grafting in the ESRD group, while exactly the same
number of patients underwent each of these pro-
cedures in the non-ESRD group.
Surgical procedures
The details of surgical procedures including conduit
types and sites of distal anastomosis in both groups
are shown in Table 2. A Dacron graft or human umbil-
ical vein (HUV) was used for bypass to the above-
knee popliteal (AKP) artery, and an autovein graft
was used for bypass to below-knee arteries, with
the reversed saphenous vein being used most fre-
quently. HUV was exclusively used for AKP bypass
until 1995, but our preference shifted to a Dacron graft
thereafter. All ischaemic limbs received complete
arterial reconstruction in principle, and anastomoses
at the AKP artery or more distal sites were performed
by non-dissection method which spares vascular
clamps.6,7 Fifty-one ischaemic limbs (78%) in non-
ESRD patients required bypass to the infragenicular
artery, while only 15 limbs (54%) in ESRD patients
underwent bypass to the infragenicular artery
(p 0.03). This result reflects the fact that six limbs
(21%) in the ESRD group, while only three limbs (5%)
in the non-ESRD group, were abandoned for distal
bypass (p 0.02) because of extensive atherosclerosis
Table 1. Demograghic characteristics and preoperative risk factors
of patients with and without ESRD.
Patients
with ESRD
Patients
without ESRD
No. of patients 22 57
No. of affected limbs 28 65
Follow-up period (months)
Mean (Range) 21 (0±65) 30 (1±106)
Age (years)
Mean (Range) 63 (41±82) 68 (45±87)
Sex
Male/female 18/4 42/15
Risk factors
Diabetes mellitus 15 (68%) 22 (38%)
Hypertension 8 (36%) 35 (51%)
CAD 11 (41%) 15 (26%)
CVD 6 (27%) 8 (16%)
Indication for operation
Infected gangrene 3 (11%) 5 (8%)
Dry gangrene 12 (43%) 27 (42%)
Non-healing ulcer 5 (18%) 17 (26%)
Rest pain alone 8 (29%) 16 (25%)
CAD: coronary artery disease. CVD: cerebrovascular disease.p 0.03.
Table 2. Number of iliac reconstruction, and conduit type and
distal anastomotic location for infrainguinal bypass of patients
with and without ESRD.
Patients
with ESRD
Patients
without ESRD
No. of affected limbs 28 65
No. of infrainguinal bypasses 33 77
No. of iliac artery reconstruction# 9 (32%) 17 (26%)
Conduit type
Prosthesis (Dacron) 5 (15%) 15 (19%)
Human umbilical vein 4 (12%) 11 (14%)
Autovein 24 (73%) 51 (66%)
Distal anastomosis
Above-knee popliteal 13 (46%) 14 (22%)
Below-knee popliteal 4 (14%) 5 (8%)
Tibial/peroneal 8 (29%) 30 (46%)
Paramalleolar 3 (11%) 16 (25%)
# Bypass grafting or percutaneous transluminal angioplasty with or
without stenting. p 0.03.
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of infragenicular arteries or lack of an appropriate
autovein graft.
Statistics
Differences between these groups were analyzed
using Student's t-test and Chi-square test. Primary or
secondary graft patency, limb salvage and survival
were estimated by the Kaplan±Meier method in
accordance with the Ad Hoc Committee on Reporting
Standards.8 The patency of reconstructed vessels was
assessed by history or physical examination sup-
plemented by Doppler pulse recordings and recently
by duplex scanning. Limb salvage was defined as
relief of rest pain or healing of ischaemic lesions, or
amputation at the level of the digit or foot.
Results
Twelve patients (55%) had systemic or local complica-
tions, and four patients among them (18%) died in the
ESRD group. In contrast, 14 patients (25%) had
complications, but no patient died in the non-ESRD
group within 30 days after operation. These results
showed higher mortality and morbidity in the ESRD
group (p 0.001 and 0.011, respectively). The causes
of early deaths were myocardial infarction in two,
cerebral infarction in one, and aspiration pneumonia
in one patient. There was no difference in periopera-
tive occurrence of graft failure and wound infection
between these groups. However, progressive necrosis
despite a patent graft was seen in two limbs of the
ESRD patients due to uncontrolled infection. Major
amputation was performed in the perioperative
period in two patients with ESRD and one patient
without ESRD due to extensive necrosis.
Follow-up is complete for all patients except
four non-ESRD patients. Nine grafts (27%) in ESRD
patients and 15 grafts (19%) in non-ESRD patients
failed during the follow-up period. By life-table
analysis, cumulative primary and secondary graft
patency at 2 years had lower rates in ESRD patients
compared with non-ESRD patients (75% vs 85%;
p 0.12 and 83% vs 91%; p 0.06, respectively) (Fig 1
for secondary graft patency), but these differences
were not significant. The use of autogenous and non-
autogenous conduits was similarly applied for bypass
grafting in both groups (Table 2). Cumulative primary
and secondary patency rates at 2 years with the use
of autogenous conduits were not different between
these groups (81% vs 80%; p 0.71 and 85% vs 90%;
p 0.37). In contrast, those rates with the use of
nonautogenous conduits revealed a significantly
poorer outcome in ESRD patients (64 vs 94%; p 0.02
and 76% vs 94%; p 0.03). Ipsilateral major amputa-
tions were required in three patients with ESRD and 4
patients without ESRD during the follow-up period
later than 30 days after revascularization. The ESRD
patients who underwent major amputations were listed
in Table 3. The cumulative limb salvage rate at 2 years
was 83% vs 93% in patients with and without ESRD.
Limb salvage was worse in patients undergoing ESRD
(p 0.06), but showed no significant difference.
Sixteen deaths occurred in patients with ESRD
during a mean follow-up period of 22 months, and
the causes of these deaths include atherosclerosis-
related disease (coronary artery disease or cerebro-
vascular disease) in nine and respiratory failure in
three patients. By life-table analysis, survival rates at
1 and 2 years were significantly poorer in dialysis-
dependent patients compared with patients with
functioning kidneys (59% vs 93% at 1 year, and 45%
vs 84% at 2 years; p5 0.001) (Fig. 2).
Discussion
The characteristic features of arterial reconstruction
for limb-threatening ischaemia due to ASO in ESRD
patients in comparison with non-ESRD patients were
as follows; (1) failure to control infection of the
affected limb despite a patent graft, (2) poorer graft
patency rate with nonautogenous conduits but
comparable graft patency with autogenous conduits,
(3) higher mortality in the perioperative period and
(4) inferior survival rate in the follow-up period.
Fig. 1. Cumulative secondary patency in patients with and without
ESRD. There was no significant difference between these rates
(p 0.06). Dotted line represents SEM4 10%. The numbers of grafts
at risk are listed at the bottom of the graph for ESRD (top row) and
non-ESRD (bottom row) groups.
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The presence of diabetes and ESRD is associated
with advanced atherosclerosis and multilevel
occlusion of arteries, often including the crural artery,
while non-diabetic and non-uremic ischaemia often
shows occlusion of the superficial femoral artery.9 In
this study, there is no difference in the distribution of
occlusive lesions between ESRD and non-ESRD
groups. This may be explained by the fact that all the
patients, whether with or without ESRD, presented
with limb-threatening ischaemia which often accom-
panies multilevel occlusive lesions. These patterns of
occlusion require bypass grafting to the below-knee
level or more distal sites. However, only a half of
reconstructions were performed to the infragenicular
artery in patients with ESRD, while nearly 80% of
grafts were bypassed to the below-knee arteries in
patients with functional kidneys. This difference is
explained by the fact that significantly more limbs
were abandoned for complete reconstruction in the
ESRD group.
The 2-year primary and secondary graft patency
rates of 75 and 83%, respectively, in ESRD patients
are not significantly different from those of non-
ESRD patients (p 0.12 and 0.06, respectively), and
comparable to those of previous reports concern-
ing arterial reconstruction in patients with renal
failure.3,10,11 Graft patency with nonautogenous con-
duits including HUV and Dacron grafts was signifi-
cantly poorer in the ESRD group. In contrast, no
significant difference was seen in graft patency with
autogenous conduits between these groups. It is
generally accepted that an autogenous vein is the
best conduit for infrainguinal revascularisation. Graft
patency and limb salvage are superior with autoveins
in comparison with nonautogenous conduits for
above-knee femoropopliteal bypass grafting,12,13
although many studies reported the use of nonauto-
genous grafts is a reasonable alternative.14±16 Auto-
vein grafts are preferable especially in ESRD patients
with foot infection because of better resistance to
infection than nonautogenous grafts.
The cumulative limb salvage rate in the ESRD
group at 2 years was lower than that in the non-
ESRD group, but the difference was not significant
(p 0.06). There were two main causes of limb loss
in the ESRD group: progressive necrosis with infection
and graft thrombosis. Early major amputation was
performed in two patients due to infection. Early
limb loss is often related to uncontrolled infection of
necrotic tissues or wound infection despite a patent
graft in patients with renal failure.10,17 This is prob-
ably due to impaired wound healing and immune
incompetence in the presence of diabetes or ESRD.18
Therefore, it is widely accepted that dialysis-
dependent patients with extensive tissue necrosis of
forefoot with infection should be offered for primary
amputation.2,19±21 Major amputation following graft
thrombosis was performed in two ESRD patients
later than 30 days after revascularisation. Poor
runoff and advanced calcification of arteries9 often
Table 3. Patients with ESRD who underwent major amputation during follow-up period.
Age,
sex
Indication
for operation
Distal site Conduit type Graft patency Amputation level Reason for
amputation
41,M Dry gangrene AKP HUV Failed (0 mo.) BK!AK (0 mo.! 1 mo.) Graft infection
71,M Dry gangrene AKP Autovein Patent BK (0 mo.) Preoperative
extensive necrosis
70,M Infected gangrene ATA Autovein Failed(1 mo.) BK(1 mo) Uncontrolled infection
despite a patent graft
74,M Rest pain AKP Dacron Failed (3 mo.) AK (4 mo.) Graft thrombosis
66,M Dry gangrene AKP/PTA y Dacron/autovein y Failed (33 mo.) AK (33 mo.) Graft thrombosis
AKP: above-knee popliteal artery, ATA: anterior tibial artery, PTA: posterior tibial artery, HUV: human umbilical vein, BK: below-knee, AK:
above-knee, mo.: month. Thrombosed after major amputation.
yDacron graft for above-knee femoropopliteal bypass and autovein graft for below-knee popliteal-PTA bypass.
Fig. 2. Patient survival in ESRD and non-ESRD groups. Overall
survival was significantly lower in the ESRD than in the non-
ESRD groups (p5 0.001). Dotted line represents SEM4 10%. The
numbers of patients at risk are listed at the bottom of the graph for
ESRD (top row) and non-ESRD (bottom row) groups.
32 H. Kimura et al.
Eur J Vasc Endovasc Surg Vol 25, January 2003
complicate bypass grafting in ESRD patients. In add-
ition, a lack of appropriate autovein grafts may neces-
sitate placement of distal anastomoses at arteries
affected by atherosclerosis.
Four perioperative deaths occurred in the ESRD
group, three of which were attributed to cardio- or
cerebrovasuclar disease. Early mortality in the ESRD
group was significantly higher than that in the non-
ESRD group (p 0.001), and similar results were
reported previously.3,22,23 Several reports proposed
that the indication for arterial reconstruction in
ESRD patients should be restricted to only limb-
threatening ischaemia because of the high postopera-
tive morbidity and mortality.19±21 None of our ESRD
patients who died in the perioperative period had
received CAG or carotid artery ultrasound prior to
bypass. Preoperative full evaluation of myocardial
and brain ischaemia may help decrease such serious
complications in the perioperative period. Thus, we
have been performing CAG and ultrasound of the
carotid arteries in as many patients as possible prior
to bypass grafting since the year 2000, although
we have not yet determined the benefit of these
procedures.
The overall survival rate at 2 years showed a
significantly poorer outcome in dialysis-dependent
patients (p5 0.001). Atherosclerosis-related diseases
are the main cause of death, accounting for 56% in
ESRD patients. In addition, the ESRD group exhibited
significantly higher prevalence of diabetes (p 0.03).
Coexisting morbidity such as diabetes, atherosclerosis
and cardiac disease determines the survival of
dialysis-dependent patients,24,25 and may explain
significantly poorer survival rate in the ESRD group.
Conclusion
Poorer outcomes with respect to perioperative mor-
tality and long-term survival in ESRD patients were
found in this study. However, graft patency and limb
salvage rates in the ESRD group were comparable to
those in the non-ESRD group, if autogenous grafts were
used. Thus, we should aggressively perform arterial
reconstruction in ESRD patients if we can reduce peri-
operative morbidity and increase the survival rate,
because successful bypass grafting greatly improves
their physical activity and thus their quality of life.
Preoperative full evaluation of myocardial and brain
ischaemia may be beneficial for that purpose. To
improve the graft patency rate in ESRD patients,
who have low resistance to infection and poor wound
healing, reconstruction with autogenous veins is
preferable.
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